Appili Therapeutics to Present Progress on Tularemia Biodefense Vaccine at NATO CBRN Conference
Appili Non-Clinical Director to join NATO and allied representatives and present ATI-1701 biodefense vaccine as a potential solution to the...
Appili Non-Clinical Director to join NATO and allied representatives and present ATI-1701 biodefense vaccine as a potential solution to the...
GAITHERSBURG, Md., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting...
Urogenital Microbiota with ABX 53 Simplicity Panel™ delivers same-day research use only results, identifying 28 organisms and 25 resistance markers in...
NEW YORK--(BUSINESS WIRE)--Biotia, a health technology company leveraging next-generation sequencing (NGS) and artificial intelligence (AI), and Hospital for Special Surgery...
NEW YORK--(BUSINESS WIRE)--Biotia, a health technology company leveraging next-generation sequencing (NGS) and artificial intelligence (AI), and Hospital for Special Surgery...
MENLO PARK, Calif., Aug. 26, 2025 /PRNewswire/ -- Avails Medical, Inc., a leader in the development of rapid, automated, and...
The healthcare analytics market is anticipated to increase due to the global shift from volume-based to value-based care models. Providers...
HOUSTON, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (IBO) is pleased to announce that the US Patent and...
BOULDER, CO / ACCESS Newswire / August 13, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and...
Emerging companies from six countries begin the 18-week startup program in Kansas' capital city TOPEKA, Kan., Aug. 13, 2025 /PRNewswire/ -- In...
Arkstone, an innovative biotechnology company democratizing infectious disease expertise and fighting antimicrobial resistance, has been acquired by global healthcare private...
Clinical case series showed clinically meaningful reductions in wound size and pain, and improved tissue regranulation in chronic wound patients...
Strategic partnership to unveil plant–based innovation for clean-label food preservation MODI'IN, Israel, July 22, 2025 /PRNewswire/ -- Biotech start-up Novella...
Partnership expected to advance 5x30 strategy by increasing ZILRETTA sales calls and extensively expanding patient access BRISBANE, CA, July 22,...
Sales Highlights (unaudited): Global Annual sales AUD$7.3 million up 49% on prior yearJune 2025 Quarter AUD$2.0 million up 55% on...
Entrance of the EAACI Congress 2025, SEC in Glasgow Entrance of the EAACI Congress in the SEC located in Glasgow...
Top global experts in crop nutrition, agronomy, and sustainable agriculture join Pivot Bio's Scientific Advisory Board to guide innovation and...
OXFORD, United Kingdom, July 16, 2025 (GLOBE NEWSWIRE) -- Vivid Dx, a precision diagnostics company transforming pathogen detection and antimicrobial...
Premier research journal article provides validation for BiomX’s phage therapy platform, showcasing first-in-human Phase 1b/2a trial results for antibiotic-resistant P....
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, July 08, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a...